Absence of demonstrable immune dysregulation in motor neuron disease (Q44624828)

4 December 2017

title

Absence of demonstrable immune dysregulation in motor neuron disease (English)

1 reference

4 December 2017

Bansal AS

1 reference

4 December 2017

Bansal JA

series ordinal

1 reference

4 December 2017

Bruce J

series ordinal

1 reference

4 December 2017

Boyle R

series ordinal

1 reference

4 December 2017

publication date

1 July 1999

1 reference

Journal of Clinical Neuroscience

4 December 2017

published in

1 reference

4 December 2017

1 reference

4 December 2017

1 reference

4 December 2017

page(s)

309-312

1 reference

Cytokine production and serum levels in systemic sclerosis

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2899%2990053-X

7 January 2021

Synovial fluid concentration of five different cytokines in rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2899%2990053-X

7 January 2021

Increased release of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2899%2990053-X

7 January 2021

Production of cytokines in sarcoid lymph nodes: preferential expression of interleukin-1 beta and interferon-gamma genes

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2899%2990053-X

7 January 2021

Detection of endogenous cytokines in sera or in lymph nodes obtained from patients with sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2899%2990053-X

7 January 2021

Evidence for autoimmunity in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2899%2990053-X

7 January 2021

Antibodies to human spinal cord proteins in sera from patients with motor neuron disease and other neurological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2899%2990053-X

7 January 2021

Serum antibodies to GM1 ganglioside in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2899%2990053-X

7 January 2021

Amyotrophic lateral sclerosis. Associated clinical disorders and immunological evaluations

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2899%2990053-X

7 January 2021

IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2899%2990053-X

7 January 2021

Experimental autoimmune motoneuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2899%2990053-X

7 January 2021

Motor neuron destruction in guinea pigs immunized with bovine spinal cord ventral horn homogenate: experimental autoimmune gray matter disease

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2899%2990053-X

7 January 2021

CD23 and B cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2899%2990053-X

7 January 2021

Soluble CD23 levels are elevated in the serum of patients with primary Sjögren's syndrome and systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2899%2990053-X

7 January 2021

El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases a

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2899%2990053-X

7 January 2021

Serum levels of interleukins 8 and 10, interferon gamma, granulocyte-macrophage colony stimulating factor and soluble CD23 in patients with primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2899%2990053-X

7 January 2021

An assessment of peripheral immunity in patients with sarcoidosis using measurements of serum vitamin D3, cytokines and soluble CD23

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2899%2990053-X

7 January 2021

Biological properties of interleukin 10.

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2899%2990053-X

7 January 2021

Serum levels of interleukin-1b, tumour necrosis factor-a and interleukin-2 in rheumatoid arthritis. Correlation with disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2899%2990053-X

7 January 2021

Elevated interleukin-10 levels in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2899%2990053-X

7 January 2021

The role of interferon gamma in the pathogenesis of Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2899%2990053-X

7 January 2021

Serum soluble CD23 in patients with hypogammaglobulinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2899%2990053-X

7 January 2021

Cytokine levels in whole blood cell cultures as parameters of the cellular immunologic activity in patients with malignant melanoma and basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2899%2990053-X

7 January 2021

Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IL-2, IFN-γ and GM-CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0967-5868%2899%2990053-X

7 January 2021

10.1016/S0967-5868(99)90053-X

Identifiers

DOI

1 reference

4 December 2017

1 reference